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Abstract
This study compares the timeliness of Electronic Laboratory Reporting (ELR)
with traditional reporting. ELR has been implemented in parts of the United States, and is
perceived to be faster than traditional reporting. Faster reporting leads to faster public
health response to prevent outbreaks, and to reduce the burden of infectious disease in
communities. Nevada State law requires that diseases be reported within certain time
frames. Timeliness of laboratory reporting at the Southern Nevada Health District
(SNHD) from 1999-2012 was assessed by analyzing cases of four common diseases in
this retrospective secondary analysis of extant data.
The difference in timeliness regarding public health response (for public health
investigation response time) and the difference in timeliness for legal state reporting
requirements between ELR and traditional reporting were evaluated using independent
samples t-tests. A two-way analysis of variance (ANOVA) was conducted to determine
whether each disease had interactions with report type or influence on timeliness.
The data contained 1,082 traditional reports and 1,343 ELR results. The diseases
in this study were campylobacteriosis, giardiasis, salmonellosis, and shigellosis. Both ttests, for public health response timeliness, and legal compliance timeliness were
statistically different. However, it was determined that public health response time
difference was not significant in later tests with a smaller confidence interval.
There was no significant interaction between disease type and report type
regarding public health response time. The result was significant regarding legal
compliance time. This study showed that with both ELR and traditional reporting, it is
impossible to prevent secondary infections when basing public health response on
laboratory confirmation. The legal requirements time was inconclusive because the data
iii

were provide in days, rather than minutes. In addition, the ANOVA for ELR and legal
time suggested batched results when using ELR. This study showed that response
timeliness is too long in Southern Nevada, with ELR and traditional reporting. More
studies of timeliness should be conducted in Southern Nevada.
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Chapter 1 – Introduction
This study compares the timeliness of traditional reporting and ELR at the
Southern Nevada Health District (SNHD). Traditional reporting includes phone, fax, and
paper reports. ELR is defined as the transmission of laboratory results sent from the
testing laboratory to the public health authorities using electronic means (Centers for
Disease Control and Prevention, [CDC] 2011a).
Faster reporting can lead to faster response by public health officials to prevent
potential outbreaks and new cases, and to reduce the burden of infectious disease in the
community. Nevada State law requires that diseases be reported in certain time frames.
For many common diseases this timeframe is within 24 hours of a test result (Nevada
Administrative Code [NAC] 441A, 2012).
Electronic Laboratory Reporting (ELR) has been or is being implemented in
many states and counties. ELR is faster and has fewer errors than traditional paper
reporting (Nguyen, Thorpe, Makki & Mostashari, 2007). In 2009, the Health Information
Technology for Economic and Clinical Health (HITECH) Act, part of the American
Recovery and Reinvestment Act (ARRA), became a law intended to expand the use of
health information technology (HIT). Health care policy experts believe that HIT can
improve quality, lower costs, and benefit the health of patients in multiple other ways.
However, the use of HIT is considered to be low (Buntin, Burke, Hoaglin, & Blumenthal,
2011). The HITECH Act makes incentive payments to healthcare providers for
implementing electronic medical records, as a part of the healthcare quality and efficacy
goal of the Patient Protection and Affordable Care Act of 2010 (Buntin, et al. 2011). In
addition to accelerating HIT, the HITECH Act provides incentive payments to reimburse
providers for meaningful use updates of electronic health systems (Lenert & Sundwall,
1

2012). Incentive payments are important because the implementation of electronic
systems can be expensive, and there has been a lack of federal funding for health IT.
Meaningful use regulations (part of HITECH) require electronic health record systems to
include incentives for healthcare providers who are able to demonstrate the ability to send
ELR data to health departments (Lenert & Sundwall, 2012).
The goal of this study is to assess the timeliness of laboratory reporting in
Southern Nevada with regard to public health response, (i.e. is the time frame sufficient
to implement appropriate public health investigations and responses to prevent and
contain potential outbreaks?). The timeliness of laboratory reporting will also be assessed
with regard to requirements set forth by Nevada state law. The objective is to discover
whether ELR is faster than traditional reporting. Timeliness will be examined from 1999,
when the Office of Epidemiology (OOE) began collecting data in a standardized database
through May 2012.
Data from four infectious gastrointestinal (GI) illnesses were analyzed in this
study, as GI infections are common in Southern Nevada; five of the top 10 illnesses
reported to the OOE at SNHD are GI infections. National reporting timeliness of these
illnesses on a case by case basis is not often very important or useful (unlike diseases
such as anthrax); however it is very important locally. This information is necessary to
contain and investigate outbreaks, which lowers the burden of disease in the community
(B.J. Labus, personal communication, February 16, 2012). The diseases in this study are
campylobacteriosis, salmonellosis, shigellosis, and giardiasis. They are the four most
common reportable GI infections in Southern Nevada for which data are collected on a
case by case basis. Outbreaks of these diseases can be fast and spread easily to children,
who can get sicker, or die more often than other populations (B.J. Labus, personal
2

communication, February 16, 2012). The type of disease was also examined with regard
to timeliness of reporting.
This is the first assessment of timeliness of reporting in Southern Nevada.

3

Chapter 2 – Background and Significance
Disease Reporting History and Policy
In the United States, infectious disease reporting legislation falls to the states. In
some states, diseases are reported to local health departments. Some local health
departments provide epidemiologic services. All US states and territories choose to
participate in a national program though the Centers for Disease Control and Prevention
(CDC) to report cases of diseases on the list of Nationally Notifiable Conditions (CDC,
1990). The list of Nationally Notifiable Conditions is based on the Council of State and
Territorial Epidemiologist’s (CSTE) position statements, and voted upon yearly by state
epidemiologists (CDC, 2012c). Reportable diseases are those that are required by state
law to be reported to state or local health authorities. Notifiable diseases are diseases that
are reported voluntarily to CDC by state or local health authorities (CDC, 2011b).
Salmonellosis, shigellosis, and giardiasis are notifiable diseases. Campylobacteriosis is
not nationally notifiable (CDC, 2011b). All of the diseases in this study are reportable in
Nevada (NAC 441A, 2012).
Although standardized reporting methods, such as the use of the Nationally
Notifiable Conditions list are fairly recent, reporting of communicable diseases to
authorities is not a new phenomenon. In 1741, in the colony of Rhode Island, tavern
owners were required by law to report customers with contagious diseases to authorities
(Smith, Hadler, Stanbury, Rolfs, & Hopkins, 2012). Voluntary disease reporting to health
authorities began in Massachusetts in 1874 (CDC, 1990). In 1878, the Public Health
Service was commissioned by Congress to collect data on cholera, smallpox, plague, and
yellow fever (Sickbert-Bennett, Weber, Poole, MacDonald, and Maillard, 2011). By
1901, all US states had reporting systems in place to report some infectious conditions to
4

the local health authorities (CDC, 1990). By 1925, all US states were participating in
national infectious disease reporting, partially due to the 1916 poliomyelitis epidemic and
1918 influenza pandemic (CDC, 1990).

History of Electronic Health Systems
Historically, health care has trailed behind other industries in adopting and
implementing electronic systems and technologies (Classen and Bates, 2011). In 1968, a
physician, Lawrence L. Weed published a paper in the New England Journal of Medicine
discussing how computers need to be used for medical records because the current state
of records was unorganized and not complete (Weed, 1968). He explained how he had
implemented computer programs in his own practice, and that by having a database with
many patients, later one could review it and revise it as needed for efficiency (Weed,
1968). Weed has been called an “innovator” by Himmelstein and Woolhandler (2005), in
their manuscript discussing history and Electronic Medical Record (EMR) systems.
Himmelstein and Woolhandler (2005) also remark that Weed’s innovation, as well as
other systems created in the 1960s and 1970s, are “optimistic,” but not practical with
regard to cost. Hospital administrators believed that they had spent a lot of money on the
electronic systems, but did not receive enough in return for them to keep the systems
running. This was, in part, due to the systems being incomplete and creating problems
such as medication errors (Himmelstein and Woolhandler, 2005).
Following in the footsteps of doctors such as Weed, a group of physicians and
informatics scientists from Indianapolis, Indiana, hospitals and the Regenstrief Institute in
Indianapolis began developing an electronic medical system in 1972. The goal of the
Regenstrief Medical Record System (RMRS) developers was to simplify records by
5

eliminating paper and reducing paperwork, as well as making information more
accessible to those who need it (McDonald et al. 1999). The Regenstrief Institute had
success with their electronic programs, and is still working to develop improved reporting
methods, and evaluating these methods (Overhage, Grannis, and McDonald, 2008).
Another evaluation of the use of technology in laboratory reporting, McLure and
Barnett (1994), made the case that paper and phone reports were inferior to facsimile
(fax) machines and personal computers. They state that the technology would produce
faster and more complete reports. One comment from McLure and Barnett’s 1994 paper
notes a challenge that is still present: “true EDI [electronic data interchange] requires a
standardized electronic format” (McLure and Barnett, 1994, Effler et al., 1999; Panackal
et al., 2002; Zarcone et al. 2010).

State and County Laws and Policy
Staes et al. (2009) explain that public health infectious disease reporting is
mandated by law in each state in the United States, and is “the key step in a chain of
events that results in public health actions.” Actions include investigation, immunization
and chemoprophylaxis, treatment of infected contacts, control measures and
identification of outbreaks. New cases of disease may occur when reports are delayed
(Staes et al. 2009).

Jajosky and Groseclose (2004) also examined disease reporting,

and stated that a comparable review of disease reporting in multiple states was not
possible, in part because states have different reporting laws and protocols. Jajosky and
Groseclose (2004) also noted that the only disease analyzed in their review that had
sufficient timeliness to contain a multistate outbreak was Hepatitis A, which has an
incubation period of 30 days. Other diseases studied such as cryptosporidiosis (7 day
6

incubation period), Escherichia coli O157:H7 (4 day incubation period), salmonellosis
(1.5 day incubation period), and shigellosis (3 day incubation period) did not have reports
that were timely enough for appropriate public health response in the event of multistate
outbreaks (Jajosky and Groseclose, 2004).
In 1998, North Carolina lawmakers amended the state’s administrative code so
that laboratories would need to report diseases that physicians already reported in hopes
that double reporting policies would improve completeness and timeliness of surveillance
(Sickbert-Bennett, et al, 2011). The researchers found that timeliness, completeness and
accuracy of reporting varied greatly by disease, but that after the implementation of the
new surveillance program, completeness of reports did increase (Sickbert-Bennett, et al.,
2011).

Traditional Laboratory Reporting
In 1984, chief epidemiologists in every state, Puerto Rico and Washington, DC
answered a survey that showed that 54% of jurisdictions required laboratory reporting of
notifiable diseases (Sacks, 1985). For notifiable and reportable diseases to meet case
definitions as “confirmed cases,” laboratory confirmation is often required (CDC, 2012c).
States are free to set their own laws regarding infectious disease reporting, as noted
earlier (CDC, 1990), and Nevada requires laboratories to report reportable and notifiable
diseases to health authorities (NAC 441A, 2012).
Another paper aiming to evaluate laboratory reporting assessed the National
Notifiable Diseases Surveillance System (NNDSS), a non-electronic system maintained
by the CDC. U.S. states territories report nationally notifiable diseases to the NNDSS.
This system was examined in a paper reviewing studies of reporting timeliness (Jajosky
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and Groseclose, 2004). Eight papers were assessed in Jajosky and Groseclose’s (2004)
manuscript; three analyzed national reporting time, and five assessed local or state
reporting timelines. Seven diseases were selected by Jajosky and Groseclose (2004) for
analysis. They used laboratory confirmation as selection criteria for the diseases. The
papers varied too much to produce comparable results, and it was suggested that other
studies should describe the processes that contribute to the timeliness measured, and a
description of the reporting process so that other papers can be compared. One of the
limitations noted in this review was that different states have different protocols which
could account for some variation in timeliness (Jajosky and Groseclose, 2004).
The U.S. is not the only country evaluating laboratory reporting timeliness.
Research from the Netherlands examined timeliness by phone, fax, e-mail or post.
Reporting rates were based on incubation period (corrected to account for latent
infectious time for two diseases), and varied from 0.4%-78.7% (after correction) of
diseases being reported within one incubation period, with this being important for
prevention of secondary infections. ELR is not used in the Netherlands; however, the
authors suggest that it should be to improve the “disappointingly large” number of
unreported infectious disease cases (Reijn, Swaan, Kretzschmar, and Steenbergen, 2011).

Electronic Laboratory Reporting
In 2006, the New York City Board of Health legally mandated ELR for notifiable
diseases. The New York City Department of Health and Mental Hygiene (NYC
DOHMH) ELR system was evaluated by interviewing informatics and surveillance
employees about the benefits and barriers to the implementation of the system. Data
examined showed that ELR was generally faster than paper (median of 6 days from
8

specimen collection to report compared to 25 days with paper), but testing that was
complex or needed multiple tests was not faster using ELR. (Nguyen et al. 2007). For
example, tuberculosis tests are conducted and reported on multiple specimens, Nguyen et
al. (2007) also reported that because syphilis is not added to a registry until after past
tests have been reviewed, ELR was not timelier (Nguyen et al. 2007).
In a similar study, research conducted at the Florida Department of Health
(FDOH) showed that the full implementation of ELR could improve timeliness (KitePowell, Hamilton, Hopkins, DePasquale, 2008). Rather than evaluate the implementation
of an electronic system, the authors assumed ELR would save time and calculated
potential improvement for four diseases. The diseases varied in increased timeliness, with
no change for meningococcal disease, 3 days faster for hepatitis A (from 13 to 10 days), 4
days faster for shigellosis (from 10 to 6 days), and 5 days faster for salmonellosis (from
12 to 7 days) (Kite-Powell et al. 2008).

Automated ELR
An evaluation of automated ELR shows faster report time (Overhage, et al. 2008;
Panackal et al. 2002; Effler et al. 1999). Automated ELR means that there is not a person
who manually sends all of the reports from the laboratory to the health department,
rather, the system is set to code results in a standardized format, and the computers
connect automatically. The Hawaii Department of Health used a prototypical automated
ELR system and found that ELR was and average of 3.8 days faster than traditional
reporting (Effler et al. 1999). Research in Allegheny County, Pennsylvania showed that
automated ELR was a median of 4 days faster than traditional reporting (Panackal et al.
2002).
9

Also evaluating automated ELR, researchers from the Regenstrief Institute
assessed timeliness in Marion County, Indiana. They found that automated ELR was 7.9
days faster than traditional reporting (Overhage et al. 2008). The investigators also
evaluated the cost after ELR implementation, and reported that after the software was
developed, there were very low maintenance costs, in part due to the standardized data
format of the system. They also reported that “the improved completeness and timeliness
of ELR reporting also lead to benefits in that the public health interventions can be
initiated at an earlier point, leading in turn to fewer lost workdays, fewer direct medical
costs, decreased probabilities that antimicrobial resistance will develop, and decreased
mortality” (Overhage et al. 2008).

Infectious Diseases and Testing Methods
Research shows that testing methods have influence over timeliness of disease
reporting (Nguyen et al. 2007; Staes et al. 2009). Multiple tuberculosis tests, as stated
above, made ELR difficult for the NYC DOHMH; as did the review of past tests for
syphilis. When multiple tests are required for a result confirmation, the time it takes to
conduct and process the results from each test factors into timeliness (Nguyen et al.
2007). Staes et al. (2009) found in a survey that 82% of urgent care providers in clinics in
Utah and Idaho ordered the recommended test for pertussis, which is a polymerase chain
reaction (PCR). The remaining 18% ordered a test that would increase reporting time
possibly by weeks (culture) or tests with low sensitivity and (direct fluorescent antibody
[DFA]) (CDC, 2006). Essentially the study by Staes et al. (2009) showed that when
providers used the wrong tests, report times could increase due to the time for the test to
produce a result. In addition, using a faster test that does not work as well can cause false
10

positives or negatives, which can lead to incorrect prevalence rates of the disease in
question (Staes et al. 2009).
In another paper examining infectious disease laboratory reporting, investigators
found that in North Carolina that diseases with laboratory-based case definitions (such as
salmonellosis) were more likely to be reported at all, as were diseases with few criteria
because laboratory reporting is more straightforward than clinician reporting (SickbertBennett, et al. 2011).
Salmonellosis is the most common reportable GI illness in Southern Nevada (B.J.
Labus, personal communication, February 16, 2012). The infection is caused by
Salmonella spp. bacteria which are ingested. Campylobacteriosis is a zoonotic bacterial
infection caused by the organism Campylobacter jejuni. Shigellosis is caused by Shigella
spp. bacteria, and can cause dysentery (Heymann, 2008). Giardiasis is a protozoal illness.
Giardia cysts are difficult to kill with chlorine, so outbreaks of giardiasis often result
from contaminated water. All of these illnesses cause diarrhea, vomiting, and other
gastrointestinal symptoms (Heymann, 2008). Although all four of these diseases are
reportable in Nevada (NAC.441A, 2012), campylobacteriosis is not a nationally
notifiable disease. Campylobacteriosis does have a standard case definition (CDC, 2012c)
(See Appendix 3 for case definitions).
Salmonellosis and shigellosis are tested using culture, as is campylobacteriosis
(Mims, Playfair, Riott, Wakelin, Williams, 1998; CDC, 2010), and giardiasis is
confirmed by an ova and parasite (O&P) exam or immunoassay (CDC, 2012a).
A study of the use and timelines of clinical disease testing in laboratories in
Georgia found that a giardiasis test (for one of three required O&P tests) could be
completed in 1 day when performed in-house rather than sent to a commercial laboratory
11

(Brzozowski, Silk, Berkelman, Loveys, & Caliendo, 2012). Brzozowski, et al. (2012)
also evaluated other diseases with regard to timeliness and found that in general, when
specimens were sent to commercial laboratories rather than tested at hospitals or clinics,
report time increased. Increased report time can cause the prevalence of diseases to
appear lower than they are, and prevent appropriate measures from being implemented in
the case of a potential outbreak (Brzozowski, 2012).
In this study, public health response time is defined as the timeframe from onset
of symptoms to the report being received at SNHD. Legal compliance time is defined as
the timeframe from the positive result in the laboratory to when SNHD received it
(Figure 1).

Figure 1. Disease Reporting Timeline
Incubation period of disease

Infection

Onset of
Symptoms

Public health response time

Specimen
Collection

Test
Result

Report to
SNHD

Legal compliance time
(24h)

Numerous studies of public health response timeliness use the onset of symptoms
to report to the health authorities to evaluate this timeframe. This timeframe is important
because it can provide public health authorities with information about epidemiologic
contacts of those who test positive. The information can be used to help prevent or
control outbreaks of disease, or to find the source of infection (Jajosky and Groseclose,
2004; Kite-Powell et al.; 2008; Reijn, Swaan, Kretzschmar, and van Steenbergen, 2011).
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This timeframe can be subjective because it is often reported by patients to clinicians.
Although, all of the diseases in this study have GI symptoms, giardiasis can be
asymptomatic in some patients (Heymann, 2008).
The legal compliance timeframe is examined to determine whether or not ELR is
faster than traditional laboratory reporting. The four diseases in this study are required to
be reported 24 hours after a result is obtained from the laboratory test (NAC 441A,
2012).
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Chapter 3 – Methods
Study Design
This study is a retrospective secondary analysis of extant data. The data were
collected as part of legally mandated public health practice. These data have not been
evaluated comparing the timeliness of ELR to traditional laboratory reporting in this way
prior to this study.

Research Questions & Hypotheses
1. How does traditional reporting compare with ELR with regard to public health
response timeliness (i.e. is the time frame sufficient to implement an appropriate public
health investigation and response to prevent and contain potential outbreaks based on
incubation period of diseases)?

Ho: There is no difference in report time.

Ha: There is a difference in report time with the prediction that ELR will be faster than
traditional reporting. It is unknown whether the timeframe for each method will provide
sufficient time for an appropriate investigation and response, if needed. It is predicted
that timeframe will be sufficient with ELR. These predictions are based on literature that
shows that the use of ELR speeds up report time.

2. How does traditional reporting compare with ELR with regard to timeliness reporting
requirements set forth by state law?

14

Ho: There is no difference in report time.

Ha: There is a difference in report time with the prediction that ELR will be faster than
traditional reporting. This prediction is based on literature showing that the use of ELR
speeds up report time.

3. What is the impact of disease type when traditional reporting is compared to ELR with
regard to public health response timeliness and legal timeliness requirements?

Ho: There is no difference in report time.

Ha: There is a difference in report time. The prediction is that ELR will be faster than
traditional reporting; however giardiasis will have the longest timeframe. This prediction
is based on literature showing that the microbiology of laboratory testing methods of
specific diseases can affect the timeliness of reports.

Variables
Predictor (X1): Report type (dichotomous: Traditional [1999-May 2004] ELR [July 2004May 2012])

Predictor (X2): Disease type (Categorical [4 categories]: Salmonellosis,
campylobacteriosis, giardiasis, shigellosis)

Outcome (Y1): Response time in days (continuous)
15

Outcome (Y2): Legal time in days (continuous)

The predictor variables are both categorical variables. The first one is
dichotomous (ELR or traditional laboratory reporting) which means that is has low
statistical power. However, the two outcome variables are both continuous, but discrete
as the data were provided in days. Continuous data are statistically more powerful
(Hulley, Cummings, Browner, Grady, & Newman, 2007). Independent samples t-tests
can be used with these variables.
The second predictor variable (disease type) is categorical, with four categories,
or four diseases. To determine interaction effects, two-way analysis of variance
(ANOVA) tests can be used (Pallant, 2007).

Data Acquisition and Ethical Concerns
The data used for this study were collected as part of legally mandated public
health surveillance activities (NAC.441A, 2012) by the Office of Epidemiology at the
Southern Nevada Health District (SNHD), as authorized by Nevada Revised Statute
[NRS] 439.
The data were de-identified to comply with NRS 441A.220 (2011). No patient
identifiers were used. The data set includes disease name and year of occurrence (See
Appendix 1: Data Dictionary). Dates were removed and the number of days between
onset date, test result, and report date, were calculated to conduct an appropriate
statistical analysis.
The reports come from two large commercial laboratories in Southern Nevada
that provide approximately 90% of SNHD’s reports (B.J. Labus, personal
16

communication, February 16, 2012). Data from the two labs only is used because
secondary infections identified by a diseases investigator could potentially be reported in
a more timely manner than reports from a laboratory, and this is an evaluation of
laboratory timeliness not investigator speed. In addition, smaller laboratories do not yet
have ELR data to compare with traditional reports (B.J. Labus, personal communication,
February 16, 2012).
The University of Nevada, Las Vegas Institutional Review Board approved an
exemption for this study in July 2012 (Protocol #1205-4153).

Inclusion and Exclusion of Data
Timeliness will be examined using four common diseases in Southern Nevada
from 1999 when the OOE began a morbidity database through May 2012. The diseases
chosen for this study are salmonellosis, campylobacteriosis, giardiasis, and shigellosis.
Figure 2 shows the ten most common diseases reported to the SNHD from 1999 to 2012.
These diseases include respiratory syncytial virus (RSV), rotavirus, novel A influenza,
salmonellosis, campylobacteriosis, giardiasis, shigellosis, aseptic meningitis, and
coccidioidomycosis (Valley Fever). RSV and novel A influenza were excluded from this
study because the data is aggregated weekly – there are no case-level data. Rotavirus was
excluded because the SNHD database was missing four years of case-level rotavirus data
(B.J. Labus, personal communication, February 16, 2012). Aseptic meningitis and
coccidioidomycosis were excluded because neither of those two diseases requires a
public health response from SNHD. This left salmonellosis, campylobacteriosis,
giardiasis, and shigellosis in the data set (Figure 2).
The Office of Epidemiology provides investigation protocols to employees via
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SNHD intranet. The following paragraphs are summaries of these protocols. Currently,
the routine investigations (not outbreak-related) for campylobacteriosis and giardiasis are
limited to children who are three years of age or younger. Prior to June 8, 2009, all
campylobacteriosis and giardiasis cases were investigated. All salmonellosis and
shigellosis cases are investigated (B.J. Labus, personal communication, October 15,
2012).
The response for campylobacteriosis includes notification of the patient’s health
care provider. If the patient is ≤3 years old, the report is from an outbreak, or the patient
works in sensitive occupation, such as food handler or child care provider, an
investigation is initiated, and information regarding the onset date, symptoms, test results,
medications, and parental occupation if the patient is a child. Education is provided to the
patient or parents about disease transmission, personal hygiene, and food safety. Children
who are positive for campylobacteriosis cannot attend child care, and workers in sensitive
occupations may not attend work until symptoms are gone (B.J. Labus, personal
communication, October 15, 2012).
The response for giardiasis is similar to the response for campylobacteriosis. In
addition to the information noted above collected for patients three years of age or
younger, parents of giardiasis cases are also questioned about travel and exposure to child
care facilities, other people with GI illness, pets, and water (drinking and recreational).
Children and contacts of children with giardiasis cannot go to child care facilities until
treatment (anti-parasitic medication) has been provided and diarrhea has stopped.
Giardiasis cases in a daycare setting are treated as potential outbreaks to identify whether
other children or staff members could have giardiasis (B.J. Labus, personal
communication, October 15, 2012).
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Salmonellosis cases are all investigated. If the case is part of an outbreak,
demographic, epidemiologic and laboratory information are collected. If the case is not
related to an outbreak, disease investigators look for matching laboratory results (from
other patients), to identify possible clusters or outbreaks. Patients are contacted and
educated regarding transmission of the disease, personal hygiene, carrier state possibility,
and food safety. Carriers of salmonellosis are uncommon, but 1% of adults and 5% of
children under age five can carry the disease asymptomatically for a year or more (B.J.
Labus, personal communication, October 15, 2012).
The infectious dose of shigellosis is very small, so it is very contagious
(Heymann, 2008). All shigellosis cases are investigated in Clark County. Demographic
information is collected from the health care provider, as well as information regarding
the disease. Laboratory results are examined to determine appropriate antibiotic
treatment. Cases are contacted and provided with information regarding transmission, the
small infectious dose, hygiene, food safety, refraining from oral and anal sex until the
bacteria is no longer detected, and disposing of diapers (B.J. Labus, personal
communication, October 15, 2012).
Control measures for salmonellosis and shigellosis include contacting school
nurses, child care management, or food establishment management regarding other
possible cases and determining when children or workers can come back. The
Environmental Health department at SNHD will be notified if infections started at child
care facilities or schools (B.J. Labus, personal communication, October 15, 2012).
The period of communicability for the four diseases in this study generally begins
at the onset of symptoms, (Heymann, 2008) which means that there will be no need for
extra calculations to account for infectious time before symptoms begin.
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The OOE does not collect sexually transmitted infection, HIV/AIDS or
tuberculosis reports, so those diseases were not considered. Further exclusion includes
cases with blank cells, negative numbers of days, and with days above 30 because these
four diseases have incubation periods that are generally less than two weeks (often only a
few days) (Heymann, 2008). Also excluded were cases in June of 2004 during the time
that ELR systems were implemented (B.J. Labus, personal communication, February 16,
2012). This was done to avoid errors from laboratory workers learning a new system.
Incubation period was used as a proxy of period of communicability, as that is common
in the literature reviewed (Jajosky and Groseclose, 2004; Kite-Powell et al. 2008).
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21
Excluded
Blank cells
Negative number of days
>30 days
June 2004

Excluded reports

Salmonellosis (n = 2,030)
Campylobacteriosis (n = 1,378)
Giardiasis (n = 1,194)
Shigellosis (n = 995)

Salmonellosis (n = 846)
Campylobacteriosis (n = 716)
Giardiasis (n = 583)
Shigellosis (n = 280)

Included reports

Complete, Case-level Data

Aseptic meningitis,
Coccidioidomycosis (Valley Fever)

No Public Health Response

Excluded

Salmonellosis, Campylobacteriosis, Giardiasis, Shigellosis,
Aseptic meningitis, Coccidioidomycosis (Valley Fever)

Public Health Response

Respiratory syncytial virus (RSV), Rotavirus, Novel A Influenza

Aggregate or Incomplete Data

Excluded

Respiratory syncytial virus (RSV), Rotavirus, Novel A Influenza, Salmonellosis, Campylobacteriosis,
Giardiasis, Shigellosis, Aseptic meningitis, Coccidioidomycosis (Valley Fever)

Top 10 Diseases

Southern Nevada, 1999-2012
SNHD Office of Epidemiology

Inclusion and Exclusion of Diseases

Figure 2. Inclusion and Exclusion Criteria for Diseases

Statistical analysis:
The first predictor variable (report type) is a dichotomous variable. The
year variable was recoded from year and month to 0 = Traditional reporting, and 1 =
ELR. The second predictor variable (disease) is a categorical variable with 4 categories.
The disease name variable was recoded from disease name to 1 = campylobacteriosis, 2 =
giardiasis, 3 = salmonellosis, 4 = shigellosis. The outcome variables (time in days) are
continuous (See data dictionary, Appendix 1).
Kolmogorov-Smirnov tests for normality were conducted. Independent samples
t-tests were used to test first two hypotheses. The Levene’s test for equal variance
(conducted automatically in an independent samples t-test) was also conducted. The level
of significance was set at p < 0.05.
Two-way analyses of variance (ANOVA) were used to test interaction effects for
the third hypothesis, one for public health response time and one for legal compliance
time. Levene’s tests for equal variances were also conducted. In a two-way ANOVA, if
the variance is unequal, a more stringent level of significance needs to be set to account
for error (Pallant, 2007). The level of significance was set at p < 0.01. A Tukey’s
Honestly Significant Difference (HSD) post-hoc test is the standard test to further explore
a two-way ANOVA. Tukey’s HSD post hoc tests were conducted. To further explore
significant interaction effects, the data set must be split by one of the interaction
categories and one-way ANOVAs with Tukey’s post hoc tests are run for each of two
categories. These tests were also conducted.
Microsoft® Excel, 2010 and IBM® SPSS® Statistics software, version 20 were
used for data management and analyses.
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Chapter 4 – Results
Data Characteristics
A total of 2,425 laboratory results were used to conduct this study. The first result
was from December of 1998, when the OOE began the morbidity database. The final
result was from May 2012. The data consisted of 1,082 traditional reports (44.6%) and
1,343 ELR results (55.4%) (Table 1).
Table 1. Frequency of Electronic and Traditional Reports
Frequency

Percent

Traditional Reports

1,082

44.6

ELR

1,343

55.4

Total

2,425

100.0

The four diseases in this study were campylobacteriosis (n = 716), giardiasis (n =
583), salmonellosis (n = 846), and shigellosis (n = 280) (Figure 3). Figure 4 shows annual
disease rates.

Number of reports

Figure 3. Frequency of Diseases

900
800
700
600
500
400
300
200
100
0

Disease
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Figure 4. Annual disease rates
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Kolmogorov-Smirnov tests for normality were conducted to determine whether to
use parametric or nonparametric statistical tests, and the data were not normally
distributed (p <0.001, violating the assumption of normality). Histograms showed slightly
negatively skewed data for public health response time reports, and positive kurtosis for
legal time reports and negative skew. In general, the distribution appeared fairly normal
(Figures 5 and 6). Due to the samples sizes containing more than 200 cases, the skew and
kurtosis should not affect the results in a significant way (Pallant, 2007). The data were
not adjusted.
Figure 5. Distribution of Public Health Response Data with Normal Curves
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Figure 6. Distribution of Legal Time Data with Normal Curves

Public Health Response Timeliness
With regard to public health response, an independent samples t-test showed a
significant difference in the timeliness in days between ELR (M = 10.84d, SD = 5.501)
and traditional reporting (M = 10.35d, SD = 6.427); t = -1.991, p = 0.047 (two-tailed).
The effect size of the differences in the means (mean difference = -0.419, 95% CI:
-0.974 to -0.007) was very small (eta squared = 0.002). The eta squared means that only
0.2% of the variance in dependent variable can be explained by the test type (ELR or
traditional reporting) (Table 2 and Table 3). Levene’s test for equality of variances
showed unequal variance (F = 23.933, p > 0.001).
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Table 2. Public Health Response Timeliness Data Characteristics
N

Mean (days)

Standard Deviation

ELR

1,343

10.84

5.501

Traditional Reports

1,082

10.35

6.427

Table 3. Public Health Response Timeliness T-test for Equality of Means
Degrees of
freedom
2134.594

T
-1.991

p

Mean difference

0.047

-0.491

95% Confidence
Interval
-0.974 to -0.007

Eta squared
0.002

Timeliness of Legal Compliance
With regard to legal time, an independent samples t-test revealed a significant
difference in time in days between ELR (M = 5.23d, SD = 2.706) and traditional
reporting (M = 4.02d, SD = 2.173); t = -12.223, p > 0.001 (two-tailed). The effect size of
the differences in the means (mean difference = -1.212, 95% CI: -1.407 to -1.018) was
moderate (eta squared = 0.058) (Table 4 and Table 5). Levene’s test for equality of
variances showed unequal variances (F = 8.836, p = 0.003). ELR was slower than
traditional reporting.

Table 4. Legal Timeliness Data Characteristics
N

Mean (days)

Standard Deviation

ELR

1,343

5.23

2.709

Traditional Reports

1,080

4.02

2.173

Table 5. Legal Response Timeliness T-Test for Equality of Means
T
-12.223

Degrees of
freedom
2420.987

p

Mean difference

0.000

-1.212
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95% Confidence
Interval
-1.407 to -1.018

Eta squared
0.058

REPORT TYPE AND DISEASE TYPE INTERACTIONS
Public Health Response Stratified by Disease
First, mean days of report type (ELR and traditional reporting) were stratified by
disease with regard to public health response time using a two-way ANOVA.
Campylobacteriosis, salmonellosis, and shigellosis were more timely with traditional
reporting, however giardiasis was faster with ELR (Figure 7).
A Levene’s test of equality of variances showed that the variance was unequal (p
< 0.001), therefore significance was set at p < 0.01 to account for error (Pallant, 2007). A
two-way ANOVA showed that disease type did not influence report type with regard to
public health response. The interaction effect was not statistically significant (F = 2.087,
p = 0.10).
There was a statistically significant difference between disease types (F = 9.402, p
< 0.001). A Tukey’s HSD post hoc test revealed that timeliness of giardiasis reports
(M = 11.71d, SD = 8.440) was significantly different from campylobacteriosis reports
(M = 10.23d, SD = 5.021), salmonellosis reports (M = 10.40d, SD = 4.853), and
shigellosis reports (M = 10.03d, SD = 4.269).
The ANOVA also revealed that with a more stringent alpha (p <0.01), timeliness
of test type was not significantly different between ELR and traditional reporting (F =
4.591,
p = 0.023). The effect size was very small (partial eta squared = 0.002) (Table 6).
Table 6. Two-Way ANOVA Results – Public Health Response Timeliness
F
p*
Partial eta squared
Disease type
4.591
0.000
0.012
0.002
Report type
4.591
0.023
Disease type*Report
Type

2.087

0.100

* Significant at p <0.01
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0.003

Figure 7. Public Health Response Time – Mean Days by Disease Type and Report Type

Legal Compliance Timeliness Stratified by Disease
Mean days for report type were then stratified by disease with regard to legal
compliance time. All diseases were more timely with traditional reporting, however
shigellosis was approximately the same (M = 5.52d for traditional reporting compared to
a mean of 5.53d for ELR) (Figure 8).
A Levene’s test of equality of variances showed that the variance was unequal for
these data as well (p < 0.001). Significance was set at p < 0.01 (Pallant, 2007). A twoway ANOVA revealed a significant interaction between report type and disease type,
suggesting that one could influence the other (F = 22.257, p < 0.001). Also significant
were differences in timeliness between disease types (F = 140.127, p < 0.001) and
between report types, as expected (F = 60.849, p < 0.001). The effect sizes were also
higher with the legal compliance time than public health time, showing that more of the
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variance in timeliness can be explained by report type or disease type (Table 7).
A Tukey’s HSD post hoc test showed that all diseases differed significantly in
average response days except campylobacteriosis (M = 4.94d, SD = 2.407) and
shigellosis (M = 5.53d, SD = 2.211) (giardiasis M = 2.86d, SD = 2.610; salmonellosis M
= 5.46d, SD = 2.084).

Table 7. Two-Way ANOVA Results – Legal Compliance Timeliness
Disease type

F
140.127

p*
0.000

Partial eta squared
0.148

Report type

60.849

0.000

0.025

Disease type*Report
Type

22.257

0.000

0.027

* Significant at p <0.01

Figure 8. Legal time – Mean days by disease type and report type

One-way ANOVAs were run (Pallant, 2007) with Tukey’s HSD post hoc tests for
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using traditional report type, showed that all diseases except salmonellosis (M = 5.24d,
SD = 1.696) and shigellosis (M = 5.52d, SD = 2.176) differed significantly from each
other in average response days (Traditional reports of campylobacteriosis M = 4.53d, SD
= 1.674; giardiasis M = 1.96d, SD = 1.349) (Table 8).
The ELR test showed only giardiasis (M = 4.15d, SD = 3.340) differing in time
from other diseases (campylobacteriosis M = 5.25d, SD = 2.812; salmonellosis M =
5.62d, SD = 2.298; shigellosis M = 5.53d, SD = 2.231).

Table 8. One-way ANOVA results – Legal Compliance time ELR compared with
Traditional Reporting
Traditional Reporting

F
278.979

p*
0.000

ELR

17.683

0.000

* Significant at p <0.01
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Chapter 5 – Discussion
The aim of this study was to evaluate the difference between traditional laboratory
reporting and ELR timeliness among two major laboratories that do infectious diseases
testing for SNHD from 1999-2012. The findings suggest that for the four GI illnesses in
this study (campylobacteriosis, giardiasis, salmonellosis, and shigellosis), traditional
reporting is faster than electronic reporting.
The data were not normally distributed. The violation of normal distribution is
common in large samples, such as the sample in this study (N = 2,425). The data were
not adjusted due to the samples sizes containing more than 200 cases. The skew and
kurtosis should not affect the results in a significant way (Pallant, 2007).
The first hypothesis, that report times between ELR and traditional reports will
differ with regard to public health response time, was supported by the initial t-test
performed. However, when further analysis was done, with a more stringent level of
significance, the difference between ELR and traditional reporting failed to be
statistically significant. The confidence interval was changed from 95% to 99% in the
two-way ANOVA because there is no two-way ANOVA post hoc test to correct for
unequal variance in the data. The way to correct for error is to change the level of
significance to p < 0.01 (Pallant, 2007). The null hypothesis cannot be rejected. With
regard to public health response (defined as the time in days between the onset of illness
and the test result reported to SNHD), it was predicted that ELR would be faster than
traditional laboratory reporting. The results showed the opposite – the mean number of
days for ELR was 10.84 (SD = 5.501), and 10.35 (SD = 6.472) for traditional reporting.
This was a significant difference when p < 0.05, but not when p < 0.01. The effect size
measured with t-tests and ANOVA was 0.002, which is very small. That means that 0.2%
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of the variance in the dependent variable (time) can be explained by the independent
variable (ELR or traditional laboratory reporting) (Pallant, 2007).
In addition to determining if ELR is faster than traditional reporting, the objective
of the public health response research question was to determine whether or not the time
frame was sufficient to implement appropriate public health investigations and responses
to prevent and contain possible outbreaks. The average number of days for all four
illnesses in both report categories is above 10 days, which suggests that neither method is
sufficient to implement public health responses. It could be impossible to prevent
secondary infections of salmonellosis and shigellosis, which both generally have
incubation periods of 1-3 days (Heymann, 2008). Although giardiasis testing can be
completed in the mandated 24-hour timeframe, confirmation can require three specimens
24 hours apart (Heymann, 2008).
The second hypothesis, which states that report times will differ between ELR
and traditional reporting with regard to timeliness requirements set forth by state law, was
supported by the t-test performed, as well as the ANOVA. This time frame is defined as
the amount of time in days between the test result in the laboratory and the report to
SNHD. State laws NAC.441A (2012), require campylobacteriosis, giardiasis,
salmonellosis, and shigellosis results to be reported within 24 hours of obtaining the
result.
The laboratories evaluated in this study use a culture to test salmonellosis,
campylobacteriosis, and shigellosis, which can take up to 72 hours to produce a result.
The laboratories have 24 hours to report the result after the culture has produced a result.
This can be up to 96 hours combined. Giardiasis is tested using an ova and parasite exam
or antigen test (which can be completed in 24 hours) (B.J. Labus, personal
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communication, February 16, 2012). However, confirmation of giardiasis by O&P
requires three separate specimens 24 hours apart (Heymann, 2008).
The results of the t-test for this hypothesis show that the difference in time
between ELR and traditional reporting was statistically significant. However, the
prediction that ELR would be faster than traditional reporting was incorrect. The average
number of days to report a result using traditional reporting was 4.02 days (SD = 2.173),
with ELR, 5.23 days (SD = 2.709). These results are very close to the time frame set forth
by state law. This research question is limited by the data, specifically a time frame
reported in days. An ideal measure for this hypothesis would have been time in hours.
The third hypothesis, whether the disease type would make a difference in time
between ELR and traditional reporting was supported by the results with regard to legal
response time. Stratification by disease was tested because the testing methods for these
diseases likely influence the timeliness. However, there was no interaction between
public health response time and report type.
Post hoc test revealed that timeliness of giardiasis reports (M = 11.71d, SD =
8.440) was significantly different from campylobacteriosis reports (M = 10.23d, SD =
5.021), salmonellosis reports (M = 10.40d, SD = 4.853), and shigellosis reports (M =
10.03d, SD = 4.269). These results agreed with the prediction that giardiasis reporting did
take longer than the other diseases, for public health response time. Campylobacteriosis,
salmonellosis, and shigellosis were more timely with traditional reporting, as seen in the
t-test, however giardiasis was slightly (though not significantly) faster with ELR – this
was a new result (M = 11.75d [SD = 8.760] for traditional reporting, and a mean of
11.65d [SD = 7.980] for ELR).
When legal compliance timeliness was examined, a two-way ANOVA revealed a
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significant interaction between report type and disease type, suggesting that disease type
could influence the timeliness of ELR or traditional reporting. Due to the significant
interaction effect, the data were split by ELR cases and traditionally reported cases, and
one-way ANOVAs were performed on each report type separately, as this is the way to
further test interactions (Pallant, 2007).
The ANOVA results for both types of reporting were significant. With traditional
reporting, there were significant differences between the report times in days of all
diseases except between salmonellosis (M = 5.24d, SD = 1.696) and shigellosis (M =
5.52d, SD = 2.176). However, when the ANOVA was run on the ELR data, the results
showed that giardiasis was the only disease with report times (M = 4.15d, SD = 3.340)
that differed significantly than the other three (campylobacteriosis M = 5.25d, SD =
2.812; salmonellosis M = 5.62d, SD = 2.298; shigellosis M = 5.53d, SD = 2.231).
This result could suggest that using ELR is resulting in more batched results from
laboratories to health authorities (for example, tests are all sent by computer one time in
a day, rather than paper reports or phone calls that could happen multiple times in a day).
Batching occurs because although all results go into a computer, the results may only be
sent to the health authorities one time each day, when someone pushes a send button.
This is common in ELR systems that are not fully automated with real time reporting
from laboratories to health authorities (B.J. Labus, personal communication, September
28, 2012). Although it does not seem practical that a laboratory worker would make a
telephone call every time a result is found, telephone calls are not as batched as electronic
reports.
As noted earlier, the traditional reporting data (M = 4.02d, SD = 2.173) for legal
compliance time was significantly faster than the ELR (M = 5.23d, SD = 2.706). This is
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also something that could be due to batching of results. An example of why this could
happen is if the lab worker has already sent the results for the day to the health authorities
at 4:58 pm, a new result shows up at 4:59 pm, and he is off work at 5:00 pm, it would not
be uncommon for him to group this result with the next day’s data, especially in cases of
diseases that require 24 hour notice, not immediate notice. If the system was fully
automated with real time ELR, the result could be immediately sent to the health
authorities. To get fully accurate data for timeliness in cases such as these, the data would
have to be analyzed in minutes, as it only takes people minutes to enter data.
Literature examining automated ELR systems shows that real time reports are
more complete and faster. Overhage et al. (2008) discovered that the real time ELR
system they used was on average eight days faster than paper reporting. Overhage et al.
(2008) also examined other systems in the US, such as the ELR used in Hawaii. They
determined that the Hawaii system, which used batched file transfer, failed with about
one third of records (either the results were not received or the results were incorrect or
incomplete) (Overhage, et al. 2008). Researchers in Allegheny County, PA found that by
using real time ELR, there were fewer errors and duplicate reports. This was due to the
use of a standardized set of results and faster reporting in general (Panackal et al. 2002).
The results of this study disagree with literature that says ELR is faster than
traditional reporting (Kite-Powell et al. 2008; Nguyen et al. 2007). However, if the
laboratories in the study were to implement fully automated, real time ELR systems, the
results might be in agreement with more of the literature.
As noted in literature above, ELR is faster, has more complete information, and
sometimes more accurate information (Kite-Powell et al. 2008; Nguyen et al. 2007;
Sickbert-Bennett et al. 2011). Many studies evaluating automated ELR have found faster
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report times. (Overhage et al. 2008; Effler et al. 1999; Panackal et al. 2002). The research
team at the Regenstrief Institute found that ELR was 7.9 days faster than traditional
laboratory reporting. They also determined that the maintenance cost after
implementation was very low (Overhage et al. 2008).
Effler et al. (1999) state that they believe ELR will improve disease reporting
quality with more complete and timely reporting. They also believe that ELR will be
more cost effective than traditional laboratory reporting because it will reduce time that it
takes for people to fill out paper forms (Effler et al, 1999).
Another benefit of using ELR found by Panackal et al. (2002) was less human
error. In evaluating their ELR system, they determined that error in completeness and
accuracy of reports was almost always caused when people were able to type free text,
rather than using standardized disease codes. In addition, almost all false positives were
caused by the use of free text, instead of standardized result codes (Panackal et al. 2002).

Limitations
There are several limitations to consider when discussing the results of this study.
First, these data were not collected for research purposes. These data were collected as a
part of legally mandated public health surveillance (NAC.441A, 2012). The research
questions and hypothesis were not conceived until after the data collection, therefore, this
is a secondary analysis.
In addition, only four diseases were studied, and while selected for convenience
(short incubation time, obvious symptoms, and high number of reports), may not be
representative of all diseases tested by the laboratories in the study. External validity may
be limited with this study as Southern Nevada is unique. There are high volumes of
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travelers, and this study does analyze diseases with short incubation periods (Las Vegas
Convention and Visitors Authority, 2011).
Data from two commercial laboratories were analyzed in this study. Reports from
one of the laboratories account for approximately 70% of laboratory results received by
SNHD. The other laboratory accounts for approximately 20% of the results received at
SNHD (B.J. Labus, personal communication, February 16, 2012). If the laboratory
sending most of the reports is the slower one, that could add bias to the study.
Another limitation specific to the public health response hypothesis is that onset
date of symptoms is often self-reported by patients. Although the beginning of a GI
illness should be fairly easy to determine, self-reported data could have recall bias.
Finally, the timeframe of the report times was provided in days. If batching is
occurring using electronic systems, it is not possible to know it from this study. Time
would need to be provided in hours or minutes to get a more accurate picture of why the
disease type does interact with report type.

Recommendations
In 2010, a new surveillance system was implemented at SNHD, which included
more automation of electronic systems (B.J. Labus, personal communication, February
16, 2012), so it is possible that the timeliness of ELR will increase as more technology is
implemented. In addition, the system could send results in real time, rather in batches.
The human component also cannot be completely ignored with ELR, because the
systems in place now are not fully automated; laboratory employees must still enter in
results and send in reports. If a human types in the wrong code or an extra number
somewhere, it can change the results completely. It could be very hard to measure human
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error, but it is expected that this will be an issue with slow times using electronic systems,
especially immediately after implementation. One way to evaluate human error is to look
for consistencies in the errors (fixed error), for instance the same wrong codes typed in
every time by a certain person. If this is the case, it would be useful to determine so that
educational interventions could take place if needed. Future studies could examine the
fixed error, if any, among laboratory results.
Effler et al. (2002) found that most human error was caused by free text, and that
standardized code sets eliminated a great deal of this error. It would be beneficial to
laboratories in Southern Nevada to implement standardized code sets to try and eliminate
human error.
Other studies to evaluate laboratories separately could also be useful in training
purposes, especially if it was found that specific laboratories had faster or slower report
times.
Full automation of ELR systems with real time reporting should be a goal for
laboratories in Southern Nevada. However, it is important to remember that some
diseases, such as highly-contagious measles, are best reported by a physician picking up a
phone because they are reportable with clinical identification by a physician, which is the
case in Nevada for certain highly infectious diseases. Viral laboratory cultures can take
weeks to produce results, which would make them useless in outbreak prevention (NAC
441A, 2012).
Another way to investigate public health response timeliness is by using
syndromic surveillance, rather than laboratory confirmation in communicable disease
outbreaks. Syndromic surveillance is a preparedness measure that examines health
indicators (such as disease symptoms) to determine whether there is a higher incidence of
39

symptoms of diseases that may lead to bigger clusters or outbreaks. It is often used in
hospital emergency departments (EDs), and is a part of the Meaningful Use regulations
(CDC, 2012b).
Researchers working with the NYC DOHMH conducted a syndromic surveillance
study in EDs. They were able to show that symptoms were signals of outbreaks; 64% of
respiratory signals and 95% of fever signals coincided with high incidence of influenza A
and B (Heffernan et al. 2004). In addition, they found that 83% of diarrhea signals and
88% of vomiting signals coincided with suspected outbreaks of norovirus and rotavirus
infections (Heffernan et al. 2004).
It could be beneficial to incorporate more syndromic surveillance activity into
disease surveillance in Southern Nevada to increase report time, in general. However, the
downside to syndromic surveillance is that while it may help to prevent outbreaks, only
laboratory tests can determine exactly what the disease is.

Conclusions
The results of this study were somewhat inconclusive with regard to whether or
not ELR is actually faster than traditional laboratory reporting. However, it is obvious
that response time from laboratories is too long when health authorities are dealing with
potential outbreaks. Testing methods of diseases can contribute to this, as can the fact that
ELR is not fully automated with real time reporting in Southern Nevada, so human error
may play a part in slow report times. In addition, standardized code sets are being
implemented, but are not fully in place in Southern Nevada laboratories.
More studies of ELR would be greatly beneficial in Southern Nevada. Further
studies to include more diseases, to evaluate human error, and to examine more aspects of
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ELR such as accuracy and completeness of reports would likely benefit SNHD and the
laboratories in Clark County. The report times are not fast enough, and more studies to
determine why need to be conducted.
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Appendix 1
Data Dictionary

Dataset prepared for Jennifer Lucas
Compiled by Brian Labus, Senior Epidemiologist

This dataset was prepared for Jennifer Lucas in response to a data request made to the
Southern Nevada Health District on April 25, 2012. The data provided have been produced in
accordance with NRS 441A.220 and HIPAA, and contain no information that could be used
individually or combined with other information to identify an individual patient. All elements of
dates have been provided as a difference between two dates, or in the case of the year
reported, the month and year of the report.

Field Name

Type

Description

disease_name

Text

test_to_report

Integer

onset_to_report

Integer

report_year

Long Integer

The name of the disease (Campylobacteriosis,
Giardiasis, Salmonellosis, Shigellosis)
The number of days between the date of the
laboratory test result and the date the test was
reported to the health department
The number of days between the reported onset of
disease and the date the disease was reported to the
health department
The month and year in which the case was reported,
in the format of YYYYMM

Recodes
Field Name

Type

Description

Recode_Name

Recode_Description

disease_name

Text

The name of the disease
(Campylobacteriosis,
Giardiasis, Salmonellosis,
Shigellosis)

disease_Recode

report_year

Long
Integer

The month and year in
which the case was
reported, in the format of
YYYYMM

ELR_Y/N

1=
Campylobacteriosos
2= Giardiasis
3= Salmonellosis
4= Shigellosis
0= Traditional
Reporting
1= ELR
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Appendix 2
List of Abbreviations
AIDS

Acquired immune deficiency syndrome

ANOVA

Analysis of variance

ARRA

American Recovery and Reinvestment Act

CDC

Centers for Disease Control and Prevention

CI

Confidence Interval

CSTE

Council of State and Territorial Epidemiologists

d

Day(s)

DFA

Direct fluorescent antibody

ED

Emergency Department

ELR

Electronic laboratory reporting

EMR

Electronic medical record

FDOH

Florida Department of Health

GI

Gastrointestinal

HIT

Health information technology

HITECH

Health Information Technology for Economic and Clinical Health

HIV

Human immunodeficiency virus

HSD

Honestly significant difference

M

Mean

NAC

Nevada Administrative Code

NNDSS

Nationally Notifiable Diseases Surveillance System

NRS

Nevada Revised Statute

NYC DOHMH

New York City Department of Mental Health and Hygiene

O&P

Ova and Parasite

OOE

Office of Epidemiology

PCR

Polymerase chain reaction

RMRS

Regenstrief Medical Record System

RSV

Respiratory Syncytial Virus

SD

Standard Deviation

SNHD

Southern Nevada Health District

US

United States
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Appendix 3
Case Definitions
Note: Definitions are reported verbatim from the public document, 2012 Case
Definitions: Nationally Notifiable Diseases and Conditions and Current Case Definitions
from the Centers for Disease Control and Prevention.
(http://wwwn.cdc.gov/nndss/document/2012_Case%20Definitions.pdf)

Campylobacteriosis (Campylobacter spp.)
2012 Case Definition
CSTE Position Statement Number: 11-ID-10
Clinical Description
A diarrheal illness of variable severity.
Laboratory Criteria for Diagnosis
Suspected
Detection of Campylobacter spp. in a clinical specimen using non-culture based
laboratory methods.
Confirmed
Isolation of Campylobacter spp. in a clinical specimen.
Case Classification
Suspected
A case that meets the suspect laboratory criteria for diagnosis.
Probable
A clinically compatible case that is epidemiologically linked to a confirmed case of
campylobacteriosis.
Confirmed
A case that meets the confirmed laboratory criteria for diagnosis.
Comment
The use of culture independent methods as standalone tests for the direct detection of
Campylobacter in stool appears to be increasing. Data available about the performance
characteristics of these assays indicates there is variability in the sensitivity, specificity
and positive predictive value of these assays depending on the test (enzyme immunoassay
(EIA) test format -lateral flow or –microplate) and manufacturer. It is therefore useful to
collect information on which type of EIA test and manufacturer are used to diagnose a
case. Culture confirmation of culture independent (e.g., EIA) test positive specimens is
ideal.
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Giardiasis
2011 Case Definition
CSTE Position Statement Number: 10-ID-17
Clinical Description
An illness caused by the protozoan Giardia lamblia (aka G. intestinalis or G. duodenalis)
and characterized by gastrointestinal symptoms such as diarrhea, abdominal cramps,
bloating, weight loss, or malabsorption.
Laboratory Criteria for Diagnosis
Laboratory-confirmed giardiasis shall be defined as the detection of Giardia organisms,
antigen, or DNA in stool, intestinal fluid, tissue samples, biopsy specimens or other
biological sample.
Case Classification
Confirmed
A case that meets the clinical description and the criteria for laboratory confirmation as
described above. When available, molecular characterization (e.g., assemblage
designation) should be reported.
Probable
A case that meets the clinical description and that is epidemiologically linked to a
confirmed
case.

Salmonellosis (Salmonella spp.)
2012 Case Definition
CSTE Position Statement Number: 11-ID-08
Clinical Description
An illness of variable severity commonly manifested by diarrhea, abdominal pain,
nausea, and sometimes vomiting. Asymptomatic infections may occur, and the organism
may cause extraintestinal infections.
Laboratory Criteria for Diagnosis
Suspect
Detection of Salmonella from a clinical specimen using a non-culture based method
Confirmed
Isolation of Salmonella from a clinical specimen

Case Classification
Suspect
A case that meets the suspect laboratory criteria for diagnosis
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Probable
A clinically compatible case that is epidemiologically linked to a confirmed case, i.e., a
contact of a confirmed case or member of a risk group as defined by public health
authorities during an outbreak.
Confirmed
A case that meets the confirmed laboratory criteria for diagnosis. When available, O and
H antigen serotype characterization should be reported.
Comment
Both asymptomatic infections and infections at sites other than the gastrointestinal tract,
if laboratory confirmed, are considered confirmed cases that should be reported.

Shigellosis (Shigella spp.)
2012 Case Definition
CSTE Position Statement Number: 11-ID-19
Clinical Description
An illness of variable severity characterized by diarrhea, fever, nausea, cramps, and
tenesmus. Asymptomatic infections may occur.
Laboratory Criteria for Diagnosis
Suspect
Detection of Shigella from a clinical specimen using a non-culture based method.
Confirmed
Isolation of Shigella from a clinical specimen.
Case Classification
Suspect
A case that meets the suspect laboratory criteria for diagnosis.
Probable
A clinically compatible case that is epidemiologically linked, i.e., is a contact of a
confirmed case or a member of a risk group defined by public health authorities during an
outbreak.
Confirmed
A case that meets the confirmed laboratory criteria for diagnosis. When available, O
antigen serotype characterization should be reported.
Comment
Both asymptomatic infections and infections at sites other than the gastrointestinal tract,
if laboratory confirmed, are considered confirmed cases that should be reported.
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